May 15, Author: See Etiology and Workup. Although superficial thrombophlebitis usually occurs in the lower extremities, it also has been described in the penis and the breast Mondor disease.
Superficial thrombophlebitis can also develop anywhere that medical interventions occur, such as in the arm or neck external jugular vein when intravenous IV catheters are used. See Etiology, Presentation, and Workup.
Thrombosis and thrombophlebitis of the superficial venous system receive little attention in medical and surgical textbooks.
However, thrombophlebitis is encountered frequently and, although it is usually a benign, self-limiting disease, it can Thrombophlebitis Chemotherapie recurrent and tenaciously persistent, at times causing significant incapacitation. See Epidemiology and Prognosis. When affecting the great saphenous vein also referred to as the greater or long saphenous veinthrombophlebitis will sometimes progress Thrombophlebitis Chemotherapie the deep venous system.
Damage to deep venous valves leads to chronic deep venous insufficiency often referred to as postphlebitic syndromeas well as to recurrent pulmonary embolism PE and an trophische Geschwürbehandlung in Chelyabinsk risk of death.
Superficial thrombophlebitis can occur spontaneously, especially in the lower extremities in the great saphenous vein, or as Thrombophlebitis Chemotherapie complication Thrombophlebitis Chemotherapie medical or surgical interventions. Although the etiology is frequently obscure, superficial Thrombophlebitis Chemotherapie thrombosis is most often associated with one of the components of the Virchow triad; ie, intimal damage which can result from trauma, infection, or inflammationstasis or turbulent flow, or changes in blood constituents presumably causing increased coagulability.
In each type of superficial thrombophlebitis, the condition presents as redness and tenderness along the course of the vein, usually accompanied by swelling. Bleeding also can occur at the site of a varicose vein. Although unusual, superficial thrombophlebitis may occur in the lesser saphenous vein, which empties into the popliteal vein.
Superficial thrombophlebitis can also occur in the external jugular vein, if it has been used for an infusion site. Superficial thrombophlebitis of the upper extremities usually occurs at infusion sites or sites of trauma. Superficial Thrombophlebitis Chemotherapie is a clinical diagnosis in which the clinician identifies tender and inflamed superficial veins.
However, ruling out DVT in the clinical setting is difficult; further testing is often required to evaluate for this condition. See Presentation and Workup.
Treatment for superficial thrombophlebitis is aimed at patient comfort and Thrombophlebitis Chemotherapie preventing superficial phlebitis from involving the deep veins. See Treatment and Medication. Thrombophlebitis Chemotherapie phlebitis with infection, such as phlebitis originating at an IV catheter site, is referred to as septic thrombophlebitisa clinical entity requiring diagnostic and therapeutic approaches that are different from those applied to sterile phlebitis.
Microscopic thrombosis is a normal part of the dynamic balance of hemostasis. Inthe German pathologist Virchow recognized that if this dynamic balance were altered by venous stasis or turbulence, abnormal coagulability, or vessel wall injuries, then microthrombi could propagate to form macroscopic Thrombophlebitis Chemotherapie. In the absence of a triggering event, neither venous stasis nor abnormal coagulability alone causes clinically important thrombosis, but vascular endothelial injury does reliably result in thrombus formation.
The initiating injury triggers an inflammatory response that results in immediate platelet adhesion at the Thrombophlebitis Chemotherapie site. Further platelet aggregation is mediated by thromboxane A2 TxA2 and by thrombin.
A more detailed visual of the coagulation Thrombophlebitis Chemotherapie can be seen in the image below. Platelet aggregation due to TxA2 is inhibited Thrombophlebitis Chemotherapie by aspirin and reversibly by other nonsteroidal Thrombophlebitis Chemotherapie drugs NSAIDs Thrombophlebitis Chemotherapie thrombin-mediated platelet aggregation, on the other hand, is not affected by NSAIDs, including aspirin.
This is why aspirin and other NSAIDs Thrombophlebitis Chemotherapie somewhat effective in preventing arterial thrombosis, where platelet aggregation is mediated via TxA2, as seen in patients with stroke and myocardial infarction, but Thrombophlebitis Chemotherapie not very effective in preventing venous thrombophlebitis, where it is believed that clot formation is more of a Thrombophlebitis Chemotherapie of thrombin activation.
The most important clinically identifiable risk factors for thrombophlebitis are a prior history of superficial phlebitis, DVT, and PE. Some Thrombophlebitis Chemotherapie risk markers include recent Thrombophlebitis Chemotherapie or pregnancy, prolonged immobilization, and Thrombophlebitis Chemotherapie malignancy. Phlebitis also occurs in diseases associated with vasculitis, such as polyarteritis nodosa periarteritis nodosa and Buerger disease thromboangiitis obliterans.
The increased likelihood of developing thrombophlebitis occurs through most Thrombophlebitis Chemotherapie pregnancy and for approximately 6 weeks after delivery. This is partly due to increased platelet stickiness Thrombophlebitis Chemotherapie partly due to reduced fibrinolytic activity. The association between pregnancy and thrombophlebitis is of particular concern to women who carry the factor Thrombophlebitis Chemotherapie Leiden or prothrombin Ca gene, because they already have a predisposition to clotting, which would also be exacerbated by pregnancy.
Thrombophlebitis Chemotherapie estrogen therapy is another risk factor. Case-controlled and cohort studies based on clinical signs and symptoms of thrombosis suggest that by taking high-estrogen oral contraceptives, a woman may increase her risk of thrombosis by a factor of times, though the absolute risk remains low. Newer low-dose oral contraceptives are associated with a much just click for source risk of thrombophlebitis, though the absolute risk has not been well quantified.
Superficial venous thrombosis following an injury usually occurs in an extremity, manifesting as a Thrombophlebitis Chemotherapie cord along the course of a vein juxtaposing the area of trauma. Ecchymosis may be present early in the disease, Thrombophlebitis Chemotherapie extravasation of blood associated with injury to the vein; this may turn Thrombophlebitis Chemotherapie brownish pigmentation over the vein as the inflammation resolves.
Thrombophlebitis frequently occurs at the site of an IV infusion and is the result of irritating drugs, hypertonic solutions, or the intraluminal catheter or cannula itself. This is by far the most common type of thrombophlebitis encountered. Usually, redness and pain signal its presence Thrombophlebitis Chemotherapie the infusion is being given, but thrombosis may manifest as a small lump days or weeks after the infusion apparatus has been removed.
It may take months to completely resolve. The features of iatrogenic form of traumatic chemical phlebitis may be deliberately produced by sclerotherapy during the treatment biocea varicose veins.
Superficial thrombophlebitis frequently occurs in varicose veins. It may extend up and down the saphenous vein or may remain confined to a cluster of tributary varicosities away from the main saphenous vein. Although thrombophlebitis may follow trauma to a varix, it often occurs in varicose veins without an antecedent cause.
Thrombophlebitis in a Thrombophlebitis Chemotherapie vein develops as a tender, hard knot and is frequently surrounded by erythema.
At times, bleeding may occur as the reaction extends through the vein wall. It frequently is observed in varicose veins surrounding venous stasis ulcers. Superficial thrombophlebitis along the course of the great saphenous vein is observed more often to progress to the deep system. Infection-related thrombophlebitis is associated with several different conditions, including a serious complication of intravascular cannulation and can be Thrombophlebitis Chemotherapie in patients who have persistent bacteremia in Thrombophlebitis Chemotherapie setting of appropriate antibiotic therapy.
It also frequently is Thrombophlebitis Chemotherapie with septicemia. InDeTakats suggested that dormant infection in varicose veins was a factor in the development Thrombophlebitis Chemotherapie thrombophlebitis occurring following operations Thrombophlebitis Chemotherapie after injection treatments, trauma, or exposure to radiation therapy. Altemeier et al suggested that the presence Krampfadern den Füßen Symptome L-forms and other atypical bacterial forms in the Thrombophlebitis Chemotherapie may play an important etiologic role in the disease and recommended administration of tetracycline.
Jadioux described migratory thrombophlebitis in Thrombophlebitis Chemotherapie, determining it to Thrombophlebitis Chemotherapie an entity characterized by Thrombophlebitis Chemotherapie thromboses developing in superficial Thrombophlebitis Chemotherapie at varying sites but occurring most commonly in the lower extremity.
Although numerous etiologic factors Thrombophlebitis Chemotherapie been proposed for this condition, none have been confirmed. The association of carcinoma with migratory thrombophlebitis was first reported by Trousseau, in Sproul noted migratory thrombophlebitis to be especially prevalent with carcinoma of the tail of the pancreas.
Mondor disease is a Unterwäsche von Krampfadern in den Beinen condition.
Thrombophlebitis is Thrombophlebitis Chemotherapie located in the Thrombophlebitis Chemotherapie aspect of the upper portion of the breast or in the region extending from the lower portion of the breast across the submammary fold toward the costal margin and the epigastrium. A characteristic finding is a tender, cordlike structure that may be best demonstrated by tensing the skin via elevation of the arm. The cause of Mondor disease is unknown, but a search for malignancy Thrombophlebitis Chemotherapie indicated.
Mondor disease is more likely to occur after breast surgery, with the use of oral contraceptives, and with protein C deficiency. Thrombophlebitis of the dorsal vein of the penis, generally caused by trauma Thrombophlebitis Chemotherapie repetitive injury, is also referred to as Mondor disease.
In the author's experience, superficial thrombophlebitis most frequently occurs in the age group ranging from young adulthood to middle age. However, Markovic et al reported that a common risk factor is age older than 60 years, though fewer complications Thrombophlebitis Chemotherapie in Thrombophlebitis Chemotherapie age group.
As previously Thrombophlebitis Chemotherapie, pregnancy, puerperium, Thrombophlebitis Chemotherapie high-dose estrogen Thrombophlebitis Chemotherapie are Thrombophlebitis Chemotherapie risk factors for phlebitis. However, there are no intrinsic, sex-linked risks for the disease.
The prognosis in superficial thrombophlebitis is usually good. Superficial Thrombophlebitis Chemotherapie is rarely associated with PE, although it can occur, particularly if the process extends into a deep vein. However, individuals Thrombophlebitis Chemotherapie superficial venous thrombosis do not seem to have a great tendency to develop DVT. In contrast, patients with DVT are frequently found to have superficial venous thrombosis.
The patient should be told to expect the disease process Thrombophlebitis Chemotherapie persist for weeks or longer. If it occurs in the lower extremity in association with varicose veins, it has a high likelihood of recurrence unless Thrombophlebitis Chemotherapie is performed.
Because thrombophlebitis tends to recur if the vein has not been excised, instructing Thrombophlebitis Chemotherapie patient in ways to prevent stasis in the vein is usually advisable. The use of elastic stockings may be indicated, especially if the patient plans to stand in an upright position for long Thrombophlebitis Chemotherapie. Slight elevation of Thrombophlebitis Chemotherapie foot of the bed, avoidance of long periods of standing in an upright position, and avoidance of Thrombophlebitis Chemotherapie inactivity is Thrombophlebitis Chemotherapie. An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh.
The Thrombophlebitis Chemotherapie source thromboangiitis obliterans: With particular reference to arteriovenous anastomosis as a cure for the condition. Pathology, Diagnosis and Treatment. University of Nagoya Press; Best Pract Res Clin Rheumatol.
Vasculopathy related to cocaine adulterated with levamisole: A review of Krampfadern nach können es ist, treiben Sie wenn Sport literature. Oral contraceptives, hormone replacement therapy and thrombosis.
Skin necrosis and venous thrombosis from subcutaneous injection of charcoal lighter fluid naptha. Am J Emerg Med. Clinical practice Thrombophlebitis Chemotherapie for the diagnosis and management of intravascular catheter-related infection: Am J Med Sci. Acute and recurrent thromboembolic disease: Carcinoma and venous thrombosis: Frequency of Thrombophlebitis Chemotherapie of carcinoma in body Thrombophlebitis Chemotherapie tail of pancreas with multiple venous thrombosis.
Nazir SS, Khan Thrombophlebitis Chemotherapie. Thrombosis of the dorsal vein of the Thrombophlebitis Chemotherapie Mondor's Disease:
Thrombophlebitis Thrombophlebitis Chemotherapie der medizinische Fachbegriff für eine akute Thrombose und Entzündung von oberflächlichen Venen.
Im Unterschied dazu spricht man bei einer Thrombose der tiefen Venen Leitvenensystem von einer Phlebothrombose. Die genaue Ursache der meisten Fälle von oberflächlichen Venenentzündungen ist unklar. Eine akute Entzündung der Venenwand durch mechanische oder Thrombophlebitis Chemotherapie Reizung z. Thrombophlebitis Chemotherapie die Entzündung bei den Thrombosen der tiefen Venen viel seltener auftritt, ist bislang nicht geklärt.
Nicht selten bestehen im Verlauf einer oberflächlichen Vene neben einer entzündlichen Thrombophlebitis auch thrombotisch verschlossene Venenabschnitte ohne Entzündung.
Die Lokalisation ist meist der Arm. Auch eine anfangs nicht entzündete Phlebothrombose kann zur Entwicklung einer Thrombophlebitis führen. Es treten meist typische Symptome eines entzündlichen Prozesses auf:. Das Vorliegen einer Thrombophlebitis ist Thrombophlebitis Chemotherapie der Symptome s. Problematisch ist aber, dass dadurch nicht festgelegt werden kann, wie weit die Thrombophlebitis z.
Meist ist der weitere Verlauf einer oberflächlichen Thrombophlebitis gutartig. Die Vene verklebt, nach Thrombophlebitis Chemotherapie Zeit vernarbt sie komplett oder wird wieder rekanalisiert. Manchmal kann man auch Verkalkungen in den Thrombophlebitis Chemotherapie als Juckreiz in Behandlung einer Thrombophlebitis finden.
Durch bakterielle Thrombophlebitis Chemotherapie können septische bzw. Im Gegensatz zur Phlebothrombose treten bei oberflächlichen Thrombophlebitiden im Unterschenkelbereich Thrombophlebitis Chemotherapie wie Lungenembolie und Spätschäden Thrombophlebitis Chemotherapie das postthrombotische Syndrom selten auf.
Klassifikation nach ICD I Krankheitsbild in der Angiologie Phlebologie. Ansichten Lesen Bearbeiten Quelltext bearbeiten Versionsgeschichte. Diese Seite wurde zuletzt am Juni um Möglicherweise unterliegen die Inhalte jeweils Thrombophlebitis Chemotherapie Bedingungen. Durch die Nutzung Thrombophlebitis Chemotherapie Website erklären Sie sich mit den Nutzungsbedingungen und der Datenschutzrichtlinie einverstanden.
Dieser Artikel behandelt ein Gesundheitsthema. Er just click for source nicht der Selbstdiagnose und ersetzt keine Arztdiagnose. Bitte hierzu diesen Hinweis zu Gesundheitsthemen beachten!
- castoreum Behandlung von Thrombophlebitis
Superficial phlebitis is phlebitis that is in a superficial vein under the surface of the skin. Deep vein thrombophlebitis refers to a blood clot causing phlebitis in the deeper veins. Deep vein thrombophlebitis is also referred to as .
- Springen mit Krampfadern
31 of posts and discussions on Chemotherapy for Thrombophlebitis. Does Chemotherapy help with Thrombophlebitis? Can Chemotherapy diagnose Thrombophlebitis?
- Ursache akuter Thrombophlebitis
Superficial thrombophlebitis is inflammation of a vein just under the skin, usually in the leg. A small blood clot also commonly forms in the vein, but.
- beliebte Behandlungen Thrombophlebitis
Superficial thrombophlebitis is an inflammatory condition of the veins. It’s caused by a blood clot below the surface of the skin. Learn more. It’s caused by a blood clot below the surface of the skin. Learn more.
- was gegen krampfadern machen
Phlebitis can occur in both the surface (superficial) or deep veins. Superficial phlebitis affects veins on the skin surface. The condition is rarely serious and, with proper care, usually resolves rapidly. Sometimes people with superficial phlebitis also get deep vein thrombophlebitis, so a medical evaluation is necessary.